Does pertussis vaccination require booster shots or is it a one-time vaccination with Diphtheria, Tetanus, and Pertussis (DTaP) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pertussis Vaccination Requires Booster Shots, Not Just One-Time Vaccination

Pertussis vaccination is not a one-time vaccination but requires multiple doses in childhood followed by booster shots throughout life to maintain immunity. 1

Childhood Vaccination Schedule

  • The primary series for pertussis vaccination consists of 5 doses of DTaP (diphtheria, tetanus, and acellular pertussis) vaccine administered during childhood before age 7 years 1
  • The recommended schedule for DTaP vaccination in children includes doses at:
    • 2 months
    • 4 months
    • 6 months
    • 15-18 months
    • 4-6 years 1
  • The fourth dose (at 15-18 months) can be administered as early as 12 months if at least 6 months have elapsed since the third dose 1
  • The fifth dose is not necessary if the fourth dose was given on or after the fourth birthday 1

Adolescent and Adult Boosters

  • After the childhood series, a booster dose of Tdap (tetanus, diphtheria, and acellular pertussis) is recommended at age 11-12 years 1, 2
  • For adults who have completed their primary series, a Tdap booster is recommended to replace one of the Td (tetanus and diphtheria) boosters 1, 3
  • Following the initial Tdap booster, tetanus and diphtheria protection should be maintained with Td boosters every 10 years 2, 3

Waning Immunity and Need for Boosters

  • Studies show that immunity to pertussis wanes over time after vaccination, making booster doses necessary 4, 5
  • Research indicates that only about 10% of children vaccinated with DTaP would remain immune to pertussis 8.5 years after the last dose 4
  • A follow-up study found that 5 years after adolescent booster immunization, pertussis toxin IgG levels were undetectable in 28% of subjects, indicating waning immunity 5

Special Considerations

  • Individuals who have recovered from laboratory-confirmed pertussis do not need additional pertussis vaccines 1
  • However, if the diagnosis was not laboratory-confirmed, pertussis vaccination should be completed as scheduled 1
  • For persons aged ≥7 years with incomplete or unknown vaccination history, at least one dose of Tdap is recommended as part of the catch-up schedule 1, 2
  • Pregnant women should receive a dose of Tdap during each pregnancy (preferably in the third trimester) to protect newborns 1, 3

Economic and Public Health Impact

  • Despite high childhood vaccination rates, pertussis incidence has been increasing, especially in adolescents and adults due to waning immunity 6, 7
  • Adolescents and adults serve as a reservoir for transmission to vulnerable infants 6
  • Cost-benefit analyses show that immunizing adolescents with Tdap is economically beneficial, potentially preventing 0.4-1.8 million cases of pertussis and saving $0.3-1.6 billion over a decade 7

Common Pitfalls to Avoid

  • Assuming that pertussis immunity from childhood vaccination lasts a lifetime - it does not 4, 5
  • Failing to administer the adolescent Tdap booster, which is crucial for maintaining immunity during the teen years 8, 6
  • Not recognizing that adults need pertussis protection too, as they can transmit the disease to vulnerable infants 6
  • Confusing DTaP (for children under 7) with Tdap (for adolescents and adults) - they contain different amounts of antigens 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Recomendaciones para la Vacuna del Tétanos Después de la Vacunación Inicial

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Immunity to pertussis 5 years after booster immunization during adolescence.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Research

Prevention of pertussis through adult vaccination.

Human vaccines & immunotherapeutics, 2015

Research

Economic considerations for pertussis booster vaccination in adolescents.

The Pediatric infectious disease journal, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.